Milestone Pharmaceuticals Inc. — Director's Dealing 2021

Mar 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2021-03-24

Reporting Person: Muller Lorenz (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-24	Employee Stock Option (right to buy)	$6.26	A	200000	Acquired	2031-03-24	Common Shares (200000)	Direct

Footnotes

F1: One-fourth (1/4th) of the shares subject to the option vest on March 24, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.